DETECTION OF ALUMINUM AND IRON IN BONE IN PATIENTS WITH CHRONIC-RENAL-FAILURE - A SURVEY

被引:0
|
作者
VANDEVYVER, FL [1 ]
DHAESE, PC [1 ]
DEBROE, ME [1 ]
机构
[1] UNIV INSTELLING ANTWERP,NEPHROL HOCHDRUCK ABT,B-2610 WILRIJK,BELGIUM
关键词
AL-DEPOSITION IN BONE; ELECTROTHERMAL ATOMIC ABSORPTION SPECTROMETRY (ETAAS); ALUMINON STAINING; LASER MICROPROBE MASS ANALYSIS (LAMMA); SECONDARY ION MASS X-RAY SPECTROMETRY (S/MS); RISK OF ADYNAMIC BONE DISEASE IN IRON OVERLOAD;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Deposition of aluminum (Al) occurs frequently in chronic renal failure. While the degree of deposition shows variations, the bone Al-content is always exceeding the normal range. Electrothermal atomic absorption spectrometry (ETAAS) proved as the preferred method of determination of Al in biological specimens. The histochemical staining of Al on the trabecular surface is a >>conditio sine qua non<< to detect Al, when an Al-induced osteopathy is suspected. Furthermore microanalytic examinations can be used to prove the histochemical findings: The laser microprobe mass analysis (LAMMA) is a useful method to identify the elements histochemically detected. Other microanalytic methods like electroprobe X-ray microanalysis (EPXMA) and the secondary ion mass spectrometry (SIMS) succeeded in ultrastructural localisation of Al in tissues. The LAMMA-technique used in undecalcified bone samples is able to verify the histochemical Aluminon staining. The investigation to elucidate the relationship between iron accumulation and the appearance of renal osteopathy proved the increased risk of adynamic bone disease in dialysis patients with iron overload.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 50 条
  • [1] BONE CONCENTRATION OF IRON AND ALUMINUM IN CHRONIC-RENAL-FAILURE - EFFECT OF DESFERRIOXAMINE THERAPY
    TOMERO, JAS
    GARCIA, MA
    RICO, J
    ALEGRE, A
    MARTIN, J
    GOMEZ, JR
    TABERNERO, JM
    NEFROLOGIA, 1986, 6 : 115 - 118
  • [2] ALUMINUM TOXICITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    ALFREY, AC
    THERAPEUTIC DRUG MONITORING, 1993, 15 (06) : 593 - 597
  • [3] ALUMINUM ACCUMULATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    TSUKAMOTO, Y
    MARUMO, F
    IWANAMI, S
    NANGO, H
    HIGASHISHIBA, H
    NAKAZAWA, R
    JAPANESE JOURNAL OF NEPHROLOGY, 1980, 22 (06): : 721 - 728
  • [4] IRON RESERVES IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    SHOSTKA, GD
    TERAPEVTICHESKII ARKHIV, 1987, 59 (08) : 97 - 102
  • [5] PARATHYROIDECTOMY DOES NOT AFFECT BONE ALUMINUM IN CHRONIC-RENAL-FAILURE
    NORDAL, KP
    DAHL, E
    HALSE, J
    HARTMANN, A
    FLATMARK, A
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 369 - 370
  • [6] ALUMINUM TOXICITY IN CHRONIC-RENAL-FAILURE
    JONES, B
    EPSTEIN, M
    CLINICAL NEPHROLOGY, 1990, 33 (05) : 257 - 257
  • [7] ALUMINUM ABSORPTION IN CHRONIC-RENAL-FAILURE
    MOCAN, MZ
    BOYCE, BF
    BRIGGS, JD
    FORWELL, MA
    HALLS, DJ
    JUNOR, BJR
    NEFROLOGIA, 1986, 6 : 87 - 90
  • [8] ALUMINUM TOXICITY IN CHRONIC-RENAL-FAILURE
    WILLS, MR
    SAUDI MEDICAL JOURNAL, 1990, 11 (03) : 174 - 180
  • [9] BONE METAL CONTENT IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    NAVARRO, JA
    GRANADILLO, VA
    SALGADO, O
    RODRIGUEZITURBE, B
    GARCIA, R
    DELLING, G
    ROMERO, RA
    CLINICA CHIMICA ACTA, 1992, 211 (03) : 133 - 142
  • [10] DIFFERENT TECHNIQUES IN THE DIAGNOSIS OF ALUMINUM STORES IN BONE IN CHRONIC-RENAL-FAILURE
    MARTIN, JLF
    RODRIGUEZ, PM
    FRAGA, PM
    LOPEZ, BD
    CANNATA, JB
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1498 - 1498